Published in Nucleosides Nucleotides Nucleic Acids on January 01, 2005
Analysis of viral and cellular factors influencing herpesvirus-induced nuclear envelope breakdown. J Virol (2012) 0.96
Inhibition of human immunodeficiency virus type-1 by cdk inhibitors. AIDS Res Ther (2010) 0.92
Compounds that target host cell proteins prevent varicella-zoster virus replication in culture, ex vivo, and in SCID-Hu mice. Antiviral Res (2010) 0.86
RNA interference for the treatment of papillomavirus disease. Open Virol J (2012) 0.80
LigProf: a simple tool for in silico prediction of ligand-binding sites. J Mol Model (2007) 0.78
The neuropsychopharmacology of criminality and aggression. Can J Psychiatry (2001) 1.15
The neurobiology of impulsive aggression. Psychiatr Clin North Am (1997) 0.90
Factors differentiating personality-disordered individuals with and without a history of unipolar mood disorder. Depress Anxiety (1999) 0.90
Event-related potentials in schizotypal personality disorder. J Neuropsychiatry Clin Neurosci (1996) 0.88
Increased morbid risk for schizophrenia-related disorders in relatives of schizotypal personality disordered patients. Arch Gen Psychiatry (1990) 0.87
D4 dopamine-receptor (DRD4) alleles and novelty seeking in substance-dependent, personality-disorder, and control subjects. Am J Hum Genet (1997) 0.86
Serotonergic function and self-injurious behavior in personality disorder patients. Psychiatry Res (1997) 0.84
Depressive response to physostigmine challenge in borderline personality disorder patients. Neuropsychopharmacology (1997) 0.84
Incidence of polypharmacy in a long-term care facility. J Am Geriatr Soc (1977) 0.79
Touch-plate and statolith formation in graviceptors of ephyrae which developed while weightless in space. Scanning Microsc (1996) 0.78
A comparison of fluvoxamine and fluoxetine in the treatment of major depression. J Clin Psychopharmacol (1996) 0.77
Diurnal neuroendocrine and autonomic function in acute and remitted depressed male patients. Biol Psychiatry (1995) 0.77
Dexamethasone suppression tests in patients with panic disorder. Am J Psychiatry (1983) 0.76
Monoamines in personality disorder. Clin Neuropharmacol (1992) 0.76
CSF somatostatin in Alzheimer's disease, depressed patients, and control subjects. Biol Psychiatry (1988) 0.75